Open original FDA record ↗Recall record
- FDA identifier
- Z-1052-2012
- Company in FDA record
- Leica Microsystems, Inc.
- FDA classification date
- Feb 17, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The primary antibodies to CD2 (clone 11F11) and CD7 (clone LP15) have been adulterated.
Source facts
- Action
- Leica Microsystems, Inc. sent a Medical Device Field Notification letter dated January 4, 2012, via first class mail on January 10, 2012, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. Customers were instructed to discontinue use of the product and to return the product to the firm. Customers who have received the affected lot numbers of the listed products were requested to return any unused/part used reagents to the Buffalo Grove, IL, location for replacement. The accounts were asked to complete the attached Acknowledgement Form, acknowledging receipt and understanding of the letter, listing the lot numbers of the units at their facility and fax it back to Leica at 1-847-607-3147. Additional questions should be addressed to the account's Leica Representative. For further questions please call (847) 405-0123
- Initiated
- 2012-01-10
- Root cause
- Labeling mix-ups
- Terminated
- 2012-04-18
- Distribution
- Worldwide Distribution -- USA (nationwide) and the country of Canada.
- Recall number
- Z-1052-2012
- Recall status
- Terminated
- CDRH record ID
- 106938
- FDA classified
- 2012-02-17
- Recall event number
- 60974